Betafuse Gel For Dogs
Betafuse is a dermatological gel with antibacterial (fusidic acid) and anti-inflammatory (betamethasone) activity. It is indicated for the treatment of acute surface pyoderma in the dog, such as acute moist dermatitis (hot spots) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
Target Species: Dogs
-
Active Ingredient
1 g contains: Active substances: Betamethasone (as betamethasone valerate) 1 mg Fusidic acid (as fusidic acid hemihydrate) 5 mg Excipients: Sodium methyl parahydroxybenzoate (E219) 3.1 mg Sodium propyl parahydroxybenzoate 0.337 mg
-
Pharmaceutical Form
Gel. An off-white to white gel.
-
Indications
For the treatment of acute surface pyoderma in the dog, such as acute moist dermatitis (hot spots) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
-
Dosage
Cutaneous use. First, the hairs covering the lesions should be gently clipped. The affected area should then be thoroughly cleaned with an antiseptic wash before daily application of the gel. The amount applied should cover the affected area in a thin layer. Apply approximately 0.5 cm length of gel per 8 cm2 of lesion, twice daily, for a minimum period of 5 days. Treatment should continue for 48 hours after the lesion has resolved. The treatment period should not exceed 7 days. If there is no response within three days, or the condition deteriorates, the diagnosis should be re-evaluated.
Prefer to speak directly to a member of our team?
Norbrook GB
We are open. Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.